Sol-gel process improved UV protection and reduced skin absorption of octyl methoxycinnamate and benzophenone-3.
This study employed a sol–gel route to fabricate mesoporous silica (MS) carriers capable of simultaneously encapsulating two widely utilized UV absorbers—benzophenone-3 (BP-3) and octyl methoxycinnamate (OMC)—resulting in the composite sunscreen agent S4M1B1. Comprehensive characterization using FTIR, TGA, UV–vis spectroscopy, DSC, SEM, and standard photoprotective indices (SPF and UVA-PF) confirmed the successful immobilization of both active ingredients within the MS porous structure, achieving a notably high loading of up to 72 wt%. Sunscreen formulations incorporating the encapsulated composite demonstrated superior photoprotective performance, exhibiting SPF and UVA-PF values approximately 40% higher than equivalent physical mixtures of the same actives. Additionally, the MS encapsulation significantly enhanced the photostability of BP-3 and OMC, effectively maintaining their UV-protective efficacy after prolonged simulated solar exposure. Franz glass diffusion cell assays further revealed that encapsulation markedly reduced the in vitro skin permeation of both BP-3 and OMC by over 55%, substantially diminishing transdermal absorption risks. The dual benefits of enhanced UV-protection efficiency and reduced dermal penetration underscore the composite’s potential as a safer and more effective active ingredient in cosmetic sunscreen products, with promising applications in advanced skincare and cosmeceutical formulations.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: